Futura Medical is the developer of innovative sexual health products, including lead product Eroxon.  Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Eroxon, Futura's clinically proven lead product, has been developed for the treatment of Erectile Dysfunction ("ED").  The highly differentiated product, which is the only topical gel treatment for ED available over the counter and helps men get an erection in ten minutes, addresses significant unmet needs in the ED market.

Our strategy is to develop our innovative product portfolio to late-stage and then partner at the optimum time to generate most value.

We are based in Guildford, UK and are listed on the AIM market of the London Stock Exchange.